Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins c-bcl-2 | 80 | 2024 | 1408 | 10.840 |
Why?
|
Apoptosis | 112 | 2024 | 9528 | 6.510 |
Why?
|
Sulfonamides | 50 | 2024 | 1982 | 5.130 |
Why?
|
Mitochondria | 58 | 2022 | 3683 | 4.430 |
Why?
|
Apoptosis Regulatory Proteins | 24 | 2021 | 1151 | 2.980 |
Why?
|
Leukemia, Myeloid, Acute | 27 | 2024 | 3626 | 2.850 |
Why?
|
Proto-Oncogene Proteins | 39 | 2024 | 4528 | 2.730 |
Why?
|
Nitrophenols | 16 | 2014 | 169 | 2.310 |
Why?
|
Drug Resistance, Neoplasm | 41 | 2024 | 5342 | 2.100 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 11 | 2019 | 88 | 2.060 |
Why?
|
bcl-X Protein | 18 | 2024 | 412 | 1.960 |
Why?
|
Biphenyl Compounds | 16 | 2014 | 1026 | 1.810 |
Why?
|
Antineoplastic Agents | 44 | 2024 | 13699 | 1.800 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 14 | 2023 | 1642 | 1.580 |
Why?
|
Neoplasms | 34 | 2023 | 22390 | 1.450 |
Why?
|
Cell Line, Tumor | 66 | 2024 | 17174 | 1.340 |
Why?
|
bcl-2-Associated X Protein | 10 | 2019 | 282 | 1.330 |
Why?
|
Peptide Fragments | 24 | 2024 | 5150 | 1.310 |
Why?
|
Thiophenes | 5 | 2021 | 570 | 1.200 |
Why?
|
Aniline Compounds | 9 | 2021 | 1094 | 1.110 |
Why?
|
Molecular Targeted Therapy | 13 | 2019 | 2830 | 1.090 |
Why?
|
Genes, bcl-2 | 7 | 2021 | 119 | 1.090 |
Why?
|
Mitochondrial Membranes | 9 | 2021 | 185 | 1.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 18 | 2021 | 11886 | 0.950 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 6 | 2023 | 71 | 0.930 |
Why?
|
Xenograft Model Antitumor Assays | 23 | 2024 | 3621 | 0.930 |
Why?
|
Cell Death | 8 | 2019 | 1682 | 0.920 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2023 | 384 | 0.870 |
Why?
|
Pyrimidines | 8 | 2021 | 3050 | 0.820 |
Why?
|
Membrane Proteins | 15 | 2014 | 7885 | 0.800 |
Why?
|
Hematologic Neoplasms | 8 | 2022 | 1907 | 0.710 |
Why?
|
Signal Transduction | 28 | 2023 | 23652 | 0.670 |
Why?
|
Pharmaceutical Preparations | 3 | 2022 | 1088 | 0.650 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2021 | 998 | 0.630 |
Why?
|
Leukemia | 5 | 2020 | 1520 | 0.630 |
Why?
|
Small Molecule Libraries | 3 | 2019 | 742 | 0.630 |
Why?
|
Neoplastic Stem Cells | 6 | 2018 | 1356 | 0.610 |
Why?
|
Tumor Cells, Cultured | 19 | 2021 | 6131 | 0.610 |
Why?
|
Neoplasms, Experimental | 4 | 2020 | 1231 | 0.610 |
Why?
|
Piperazines | 18 | 2021 | 2553 | 0.600 |
Why?
|
Animals | 92 | 2024 | 169408 | 0.600 |
Why?
|
Azacitidine | 7 | 2024 | 336 | 0.590 |
Why?
|
Drug Design | 6 | 2018 | 1046 | 0.590 |
Why?
|
Sports | 1 | 2024 | 703 | 0.580 |
Why?
|
Humans | 178 | 2024 | 768887 | 0.560 |
Why?
|
Lymphoma, B-Cell | 2 | 2018 | 945 | 0.550 |
Why?
|
Mice | 65 | 2024 | 82074 | 0.540 |
Why?
|
Adaptive Immunity | 1 | 2021 | 733 | 0.520 |
Why?
|
Neoplasm Proteins | 10 | 2019 | 3608 | 0.520 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2023 | 8664 | 0.510 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 6 | 2021 | 1437 | 0.500 |
Why?
|
Drug Synergism | 10 | 2021 | 1762 | 0.480 |
Why?
|
Protein Kinase Inhibitors | 12 | 2022 | 5707 | 0.470 |
Why?
|
Cell Survival | 17 | 2018 | 5794 | 0.470 |
Why?
|
Military Personnel | 1 | 2024 | 1264 | 0.470 |
Why?
|
Cytochromes c | 7 | 2017 | 173 | 0.460 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2021 | 2960 | 0.450 |
Why?
|
Gene Expression Regulation, Leukemic | 7 | 2020 | 658 | 0.450 |
Why?
|
Paclitaxel | 5 | 2020 | 1735 | 0.450 |
Why?
|
Killer Cells, Natural | 2 | 2022 | 2211 | 0.430 |
Why?
|
Membrane Potential, Mitochondrial | 6 | 2016 | 297 | 0.420 |
Why?
|
Peptides | 6 | 2018 | 4353 | 0.420 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 778 | 0.420 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2016 | 622 | 0.420 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2019 | 1560 | 0.420 |
Why?
|
Breast Neoplasms | 13 | 2022 | 21187 | 0.410 |
Why?
|
Medical Oncology | 2 | 2021 | 2350 | 0.390 |
Why?
|
ras Proteins | 4 | 2022 | 1058 | 0.390 |
Why?
|
Lung Neoplasms | 8 | 2021 | 13593 | 0.380 |
Why?
|
Stromal Cells | 3 | 2013 | 1337 | 0.360 |
Why?
|
Flow Cytometry | 4 | 2016 | 5905 | 0.360 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2543 | 0.350 |
Why?
|
Drug Therapy | 1 | 2013 | 504 | 0.350 |
Why?
|
Multiple Myeloma | 7 | 2022 | 5195 | 0.350 |
Why?
|
Etoposide | 3 | 2019 | 639 | 0.340 |
Why?
|
Immunotherapy | 3 | 2022 | 4755 | 0.330 |
Why?
|
Protein Processing, Post-Translational | 4 | 2018 | 1966 | 0.330 |
Why?
|
Protein Interaction Domains and Motifs | 4 | 2016 | 450 | 0.320 |
Why?
|
Immunity, Innate | 1 | 2021 | 3080 | 0.320 |
Why?
|
Permeability | 4 | 2016 | 726 | 0.310 |
Why?
|
Mice, SCID | 9 | 2021 | 2631 | 0.310 |
Why?
|
Minor Histocompatibility Antigens | 5 | 2019 | 304 | 0.300 |
Why?
|
Drug Delivery Systems | 4 | 2019 | 2238 | 0.300 |
Why?
|
Models, Biological | 9 | 2016 | 9499 | 0.300 |
Why?
|
Granulocyte Precursor Cells | 3 | 2024 | 49 | 0.300 |
Why?
|
Epidermolysis Bullosa Simplex | 5 | 1994 | 12 | 0.290 |
Why?
|
Drug Screening Assays, Antitumor | 6 | 2018 | 719 | 0.290 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2023 | 494 | 0.280 |
Why?
|
Estrogen Receptor alpha | 2 | 2021 | 581 | 0.280 |
Why?
|
Cytarabine | 2 | 2019 | 697 | 0.280 |
Why?
|
MAP Kinase Signaling System | 4 | 2022 | 1494 | 0.280 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2021 | 5434 | 0.270 |
Why?
|
Ovarian Neoplasms | 5 | 2019 | 4919 | 0.260 |
Why?
|
DNA Damage | 6 | 2020 | 2472 | 0.260 |
Why?
|
Receptors, Estrogen | 2 | 2021 | 2252 | 0.260 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2016 | 230 | 0.250 |
Why?
|
Thymus Gland | 2 | 2010 | 1266 | 0.250 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 906 | 0.250 |
Why?
|
Mitochondria, Liver | 1 | 2006 | 190 | 0.250 |
Why?
|
Myeloproliferative Disorders | 3 | 2018 | 616 | 0.250 |
Why?
|
Cell Communication | 1 | 2012 | 1660 | 0.240 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2149 | 0.240 |
Why?
|
Lymphocytes | 2 | 2012 | 2614 | 0.240 |
Why?
|
Benzamides | 3 | 2017 | 1387 | 0.240 |
Why?
|
Cell Membrane Permeability | 4 | 2018 | 573 | 0.230 |
Why?
|
Keratins | 5 | 1994 | 502 | 0.230 |
Why?
|
Protein Binding | 9 | 2019 | 9344 | 0.230 |
Why?
|
Urodela | 1 | 2024 | 18 | 0.230 |
Why?
|
Mythology | 1 | 2024 | 15 | 0.230 |
Why?
|
Leukemia, Lymphoid | 1 | 2004 | 312 | 0.230 |
Why?
|
Mice, Inbred NOD | 9 | 2021 | 1839 | 0.230 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 414 | 0.230 |
Why?
|
Caspases | 3 | 2023 | 881 | 0.220 |
Why?
|
Growth Substances | 1 | 2006 | 760 | 0.220 |
Why?
|
Oncogene Proteins | 1 | 2007 | 718 | 0.220 |
Why?
|
Karyopherins | 2 | 2015 | 134 | 0.220 |
Why?
|
Smallpox | 1 | 2003 | 43 | 0.210 |
Why?
|
Cell Line | 10 | 2021 | 15603 | 0.210 |
Why?
|
Drug Resistance, Multiple | 1 | 2024 | 255 | 0.210 |
Why?
|
bcl-Associated Death Protein | 3 | 2014 | 102 | 0.210 |
Why?
|
Spheroids, Cellular | 2 | 2017 | 331 | 0.210 |
Why?
|
Cell Proliferation | 16 | 2021 | 10486 | 0.210 |
Why?
|
Intermediate Filament Proteins | 2 | 1995 | 262 | 0.200 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.200 |
Why?
|
Immunoglobulin Variable Region | 1 | 2023 | 420 | 0.200 |
Why?
|
Culture Media, Conditioned | 1 | 2023 | 521 | 0.200 |
Why?
|
Amino Acid Sequence | 11 | 2016 | 13427 | 0.190 |
Why?
|
Organ Specificity | 3 | 2016 | 1970 | 0.190 |
Why?
|
Macrophages | 1 | 2017 | 5800 | 0.190 |
Why?
|
Mutation | 18 | 2022 | 30266 | 0.190 |
Why?
|
Janus Kinase 2 | 2 | 2015 | 560 | 0.190 |
Why?
|
Confusion | 1 | 2024 | 278 | 0.190 |
Why?
|
Disease Models, Animal | 10 | 2022 | 18366 | 0.190 |
Why?
|
Zebrafish Proteins | 1 | 2008 | 1019 | 0.190 |
Why?
|
Female | 45 | 2022 | 397464 | 0.190 |
Why?
|
Viral Proteins | 2 | 2007 | 1802 | 0.180 |
Why?
|
Immunoprecipitation | 4 | 2016 | 874 | 0.180 |
Why?
|
Thionucleotides | 2 | 2012 | 107 | 0.180 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 428 | 0.180 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2019 | 36 | 0.170 |
Why?
|
Hematopoietic Stem Cells | 3 | 2018 | 3408 | 0.170 |
Why?
|
Mitoxantrone | 1 | 2019 | 148 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2911 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 859 | 0.170 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
Inhibitory Concentration 50 | 2 | 2018 | 466 | 0.160 |
Why?
|
Quinazolines | 3 | 2018 | 1373 | 0.160 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 321 | 0.160 |
Why?
|
Maximum Tolerated Dose | 2 | 2018 | 899 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2021 | 2460 | 0.160 |
Why?
|
HCT116 Cells | 3 | 2016 | 405 | 0.160 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2015 | 4413 | 0.160 |
Why?
|
Pyrroles | 3 | 2012 | 1126 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 506 | 0.150 |
Why?
|
Doxorubicin | 3 | 2018 | 2234 | 0.150 |
Why?
|
Epoxy Compounds | 1 | 2018 | 137 | 0.150 |
Why?
|
Structure-Activity Relationship | 6 | 2017 | 3056 | 0.150 |
Why?
|
DNA Fingerprinting | 1 | 2018 | 114 | 0.150 |
Why?
|
Leiomyosarcoma | 1 | 2022 | 425 | 0.150 |
Why?
|
Protein Structure, Tertiary | 4 | 2014 | 3775 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2021 | 1903 | 0.150 |
Why?
|
Mitochondrial Membrane Transport Proteins | 2 | 2016 | 170 | 0.150 |
Why?
|
Genomics | 7 | 2021 | 5928 | 0.150 |
Why?
|
Biomimetic Materials | 2 | 2017 | 173 | 0.150 |
Why?
|
Dimerization | 2 | 2010 | 886 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2014 | 4651 | 0.140 |
Why?
|
RNA Stability | 1 | 2019 | 321 | 0.140 |
Why?
|
Immunophenotyping | 1 | 2022 | 1866 | 0.140 |
Why?
|
Macrolides | 1 | 2018 | 205 | 0.140 |
Why?
|
Histone Demethylases | 1 | 2020 | 328 | 0.140 |
Why?
|
Phagocytosis | 2 | 2017 | 1530 | 0.140 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2022 | 1320 | 0.140 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2017 | 2433 | 0.140 |
Why?
|
Enzyme Inhibitors | 2 | 2018 | 3724 | 0.140 |
Why?
|
Graft vs Host Disease | 2 | 2024 | 3048 | 0.140 |
Why?
|
Oxadiazoles | 1 | 2017 | 94 | 0.140 |
Why?
|
Thiazoles | 2 | 2021 | 1542 | 0.140 |
Why?
|
Molecular Sequence Data | 9 | 2014 | 17629 | 0.140 |
Why?
|
Dendritic Cells | 2 | 2019 | 2748 | 0.140 |
Why?
|
Aneuploidy | 1 | 2020 | 573 | 0.140 |
Why?
|
Gene Expression Profiling | 5 | 2016 | 9549 | 0.140 |
Why?
|
Urothelium | 1 | 2019 | 276 | 0.140 |
Why?
|
Peptide Library | 2 | 2016 | 351 | 0.140 |
Why?
|
Drug Combinations | 1 | 2023 | 2088 | 0.140 |
Why?
|
Receptors, Notch | 1 | 2021 | 751 | 0.140 |
Why?
|
Gene Expression | 5 | 2022 | 7602 | 0.130 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3951 | 0.130 |
Why?
|
Wilms Tumor | 1 | 2019 | 378 | 0.130 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 582 | 0.130 |
Why?
|
Intermediate Filaments | 4 | 1995 | 171 | 0.130 |
Why?
|
Pyrazines | 2 | 2017 | 1206 | 0.130 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2017 | 158 | 0.130 |
Why?
|
Cytoplasm | 2 | 2018 | 1505 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 308 | 0.130 |
Why?
|
Genes, myc | 2 | 2009 | 391 | 0.130 |
Why?
|
Myofibroblasts | 1 | 2017 | 230 | 0.130 |
Why?
|
Pyrazoles | 2 | 2017 | 2029 | 0.130 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6856 | 0.130 |
Why?
|
Thrombocytopenia | 2 | 2020 | 1181 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2021 | 5716 | 0.120 |
Why?
|
Immunoblotting | 2 | 2010 | 1647 | 0.120 |
Why?
|
Ubiquitin | 3 | 2017 | 843 | 0.120 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
Tissue Fixation | 1 | 2016 | 245 | 0.120 |
Why?
|
Protein Structure, Secondary | 2 | 2016 | 1216 | 0.120 |
Why?
|
RNA, Small Interfering | 4 | 2019 | 3433 | 0.120 |
Why?
|
Lymphoma | 3 | 2016 | 1900 | 0.120 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2139 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 9442 | 0.120 |
Why?
|
Neoplasm Transplantation | 4 | 2021 | 2018 | 0.120 |
Why?
|
Aged, 80 and over | 10 | 2020 | 59738 | 0.120 |
Why?
|
Principal Component Analysis | 1 | 2017 | 948 | 0.120 |
Why?
|
Remission Induction | 3 | 2020 | 2411 | 0.120 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2019 | 454 | 0.110 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 465 | 0.110 |
Why?
|
Phosphorylation | 5 | 2018 | 8317 | 0.110 |
Why?
|
Macrophage Activation | 1 | 2017 | 556 | 0.110 |
Why?
|
Topoisomerase Inhibitors | 1 | 2013 | 19 | 0.110 |
Why?
|
Sequence Deletion | 1 | 2018 | 1498 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 2017 | 693 | 0.110 |
Why?
|
HeLa Cells | 3 | 2016 | 3076 | 0.110 |
Why?
|
Hydrazines | 1 | 2015 | 223 | 0.110 |
Why?
|
Thalidomide | 1 | 2019 | 886 | 0.110 |
Why?
|
Digitonin | 1 | 2013 | 25 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 3 | 2019 | 2813 | 0.110 |
Why?
|
Disease Outbreaks | 1 | 2003 | 1761 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1105 | 0.110 |
Why?
|
Base Sequence | 5 | 2019 | 12430 | 0.110 |
Why?
|
Fluorometry | 1 | 2013 | 99 | 0.110 |
Why?
|
Cell Division | 1 | 2020 | 4478 | 0.110 |
Why?
|
Administration, Oral | 3 | 2018 | 4042 | 0.110 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 195 | 0.100 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 308 | 0.100 |
Why?
|
Mice, Nude | 5 | 2019 | 3631 | 0.100 |
Why?
|
Male | 26 | 2021 | 365249 | 0.100 |
Why?
|
Immunoconjugates | 1 | 2020 | 976 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2019 | 65485 | 0.100 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2015 | 240 | 0.100 |
Why?
|
Purines | 2 | 2014 | 615 | 0.100 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2012 | 94 | 0.100 |
Why?
|
Biological Assay | 1 | 2015 | 628 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2014 | 2884 | 0.100 |
Why?
|
Indoles | 2 | 2012 | 1836 | 0.100 |
Why?
|
Single-Cell Analysis | 3 | 2023 | 2542 | 0.100 |
Why?
|
Survival Analysis | 4 | 2018 | 10115 | 0.100 |
Why?
|
Thromboembolism | 1 | 1999 | 1004 | 0.100 |
Why?
|
Brain Ischemia | 1 | 2005 | 3008 | 0.100 |
Why?
|
RNA Interference | 4 | 2019 | 2835 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1081 | 0.100 |
Why?
|
Genes, p53 | 3 | 2020 | 716 | 0.100 |
Why?
|
Mice, Transgenic | 6 | 2021 | 9564 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4862 | 0.100 |
Why?
|
Plasma Cells | 1 | 2015 | 599 | 0.100 |
Why?
|
Aged | 12 | 2020 | 171790 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 493 | 0.090 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1082 | 0.090 |
Why?
|
Aminopyridines | 1 | 2015 | 580 | 0.090 |
Why?
|
B-Lymphocytes | 3 | 2019 | 4794 | 0.090 |
Why?
|
Vincristine | 2 | 2018 | 1040 | 0.090 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2012 | 355 | 0.090 |
Why?
|
Anemia | 1 | 2020 | 1516 | 0.090 |
Why?
|
Tumor Burden | 1 | 2017 | 1913 | 0.090 |
Why?
|
Quinazolinones | 1 | 2012 | 219 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 478 | 0.090 |
Why?
|
Glioblastoma | 2 | 2017 | 3525 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 620 | 0.090 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1993 | 1683 | 0.090 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 457 | 0.090 |
Why?
|
Interleukins | 1 | 2015 | 796 | 0.090 |
Why?
|
Endoribonucleases | 1 | 2012 | 231 | 0.090 |
Why?
|
Cross-Priming | 1 | 2010 | 75 | 0.090 |
Why?
|
Protein Kinases | 1 | 2017 | 1611 | 0.090 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 686 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 864 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1806 | 0.090 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 239 | 0.080 |
Why?
|
Triazoles | 1 | 2015 | 904 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 742 | 0.080 |
Why?
|
Ubiquitination | 1 | 2014 | 1010 | 0.080 |
Why?
|
Survival Rate | 3 | 2021 | 12873 | 0.080 |
Why?
|
P-Selectin | 1 | 2011 | 599 | 0.080 |
Why?
|
Multigene Family | 2 | 2010 | 1082 | 0.080 |
Why?
|
Tumor Stem Cell Assay | 1 | 2008 | 116 | 0.080 |
Why?
|
Metabolomics | 1 | 2018 | 1675 | 0.080 |
Why?
|
DNA Repair | 1 | 2018 | 2054 | 0.080 |
Why?
|
Half-Life | 1 | 2009 | 651 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2336 | 0.080 |
Why?
|
T-Lymphocytes | 5 | 2024 | 10276 | 0.080 |
Why?
|
Coculture Techniques | 1 | 2012 | 1342 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1469 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3785 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2986 | 0.080 |
Why?
|
Cell Lineage | 3 | 2016 | 2576 | 0.080 |
Why?
|
Transplantation, Homologous | 4 | 2024 | 4835 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2018 | 22381 | 0.070 |
Why?
|
Bone Marrow Cells | 2 | 2012 | 2414 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1674 | 0.070 |
Why?
|
Point Mutation | 1 | 1993 | 1595 | 0.070 |
Why?
|
Annexin A5 | 1 | 2007 | 104 | 0.070 |
Why?
|
Chromatography, Affinity | 1 | 1988 | 525 | 0.070 |
Why?
|
Dexamethasone | 1 | 2015 | 1965 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4593 | 0.070 |
Why?
|
Autophagy | 1 | 2015 | 1351 | 0.070 |
Why?
|
Caspase 9 | 1 | 2007 | 184 | 0.070 |
Why?
|
Immunoglobulin M | 1 | 2012 | 1528 | 0.070 |
Why?
|
Electron Transport Complex IV | 1 | 2007 | 192 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2013 | 1750 | 0.070 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2022 | 566 | 0.070 |
Why?
|
Binding, Competitive | 1 | 2008 | 1142 | 0.070 |
Why?
|
Recurrence | 2 | 2020 | 8512 | 0.070 |
Why?
|
Cells, Cultured | 8 | 2018 | 19023 | 0.070 |
Why?
|
Middle Aged | 10 | 2020 | 223740 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2021 | 4291 | 0.070 |
Why?
|
Enzyme Activators | 1 | 2006 | 56 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2250 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1251 | 0.070 |
Why?
|
Up-Regulation | 2 | 2018 | 4148 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2015 | 1597 | 0.060 |
Why?
|
Sulfones | 1 | 2008 | 448 | 0.060 |
Why?
|
Clone Cells | 2 | 2021 | 1670 | 0.060 |
Why?
|
Fibroblasts | 1 | 2016 | 4178 | 0.060 |
Why?
|
Proteomics | 4 | 2023 | 3913 | 0.060 |
Why?
|
Radiation Tolerance | 1 | 2008 | 478 | 0.060 |
Why?
|
Glucose | 1 | 2017 | 4352 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2013 | 11262 | 0.060 |
Why?
|
Blotting, Western | 2 | 2017 | 5035 | 0.060 |
Why?
|
Gene Dosage | 1 | 2010 | 1222 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4363 | 0.060 |
Why?
|
Wnt Proteins | 1 | 2009 | 725 | 0.060 |
Why?
|
Nucleic Acid Conformation | 1 | 1988 | 901 | 0.060 |
Why?
|
Intracellular Membranes | 1 | 2006 | 388 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1933 | 0.060 |
Why?
|
Mesothelioma | 1 | 2011 | 811 | 0.060 |
Why?
|
Glycosylation | 1 | 2008 | 1101 | 0.060 |
Why?
|
Interleukin-3 | 1 | 2006 | 425 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9213 | 0.060 |
Why?
|
Adult | 9 | 2023 | 223818 | 0.060 |
Why?
|
Leukemia, B-Cell | 1 | 2004 | 86 | 0.060 |
Why?
|
Serine | 1 | 2008 | 831 | 0.060 |
Why?
|
beta Catenin | 1 | 2009 | 1047 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4607 | 0.060 |
Why?
|
Prognosis | 3 | 2021 | 30044 | 0.060 |
Why?
|
Cisplatin | 2 | 2020 | 1661 | 0.060 |
Why?
|
Keratinocytes | 3 | 1993 | 876 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2008 | 2749 | 0.060 |
Why?
|
Genome, Human | 1 | 2016 | 4456 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2007 | 682 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39394 | 0.050 |
Why?
|
Phenotype | 4 | 2017 | 16735 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 18454 | 0.050 |
Why?
|
Lactones | 1 | 2005 | 316 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3253 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3671 | 0.050 |
Why?
|
Anticoagulants | 1 | 1999 | 4850 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 1952 | 0.050 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 508 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2002 | 123 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4064 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4300 | 0.050 |
Why?
|
Doxycycline | 1 | 2004 | 349 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2010 | 1410 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10778 | 0.050 |
Why?
|
Molecular Mimicry | 1 | 2003 | 213 | 0.050 |
Why?
|
Janus Kinase 3 | 1 | 2022 | 76 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 752 | 0.050 |
Why?
|
Cell Differentiation | 4 | 2017 | 11684 | 0.050 |
Why?
|
Transfection | 3 | 2016 | 5763 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9618 | 0.050 |
Why?
|
Protein Interaction Mapping | 2 | 2018 | 621 | 0.050 |
Why?
|
Boronic Acids | 1 | 2005 | 915 | 0.050 |
Why?
|
Transplantation, Isogeneic | 1 | 2021 | 249 | 0.050 |
Why?
|
Bone Marrow | 1 | 2011 | 2935 | 0.050 |
Why?
|
Daptomycin | 1 | 2021 | 71 | 0.050 |
Why?
|
Naphthoquinones | 1 | 2021 | 59 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2010 | 2055 | 0.050 |
Why?
|
Busulfan | 1 | 2021 | 259 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 2017 | 8055 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2002 | 739 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2012 | 3473 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3714 | 0.050 |
Why?
|
Central Nervous System | 1 | 2008 | 1345 | 0.040 |
Why?
|
Benzofurans | 1 | 2021 | 139 | 0.040 |
Why?
|
Adenine | 2 | 2017 | 995 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 233 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6401 | 0.040 |
Why?
|
Genes, cdc | 1 | 2020 | 114 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1658 | 0.040 |
Why?
|
Vidarabine | 1 | 2021 | 337 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2021 | 317 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 3116 | 0.040 |
Why?
|
History, 21st Century | 1 | 2006 | 1575 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2014 | 1741 | 0.040 |
Why?
|
Tristetraprolin | 1 | 2019 | 40 | 0.040 |
Why?
|
Leukopenia | 1 | 2020 | 212 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2002 | 902 | 0.040 |
Why?
|
Trisomy | 1 | 2020 | 260 | 0.040 |
Why?
|
Disease Progression | 4 | 2019 | 13677 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 417 | 0.040 |
Why?
|
Cohort Studies | 2 | 2019 | 41800 | 0.040 |
Why?
|
Models, Molecular | 3 | 2017 | 5404 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2022 | 354 | 0.040 |
Why?
|
Macrocyclic Compounds | 1 | 2018 | 67 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6546 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2016 | 2488 | 0.040 |
Why?
|
Drug Discovery | 2 | 2016 | 1068 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2771 | 0.040 |
Why?
|
Transcription Factors | 3 | 2023 | 12174 | 0.040 |
Why?
|
Spliceosomes | 1 | 2018 | 116 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 380 | 0.040 |
Why?
|
Cell Cycle | 2 | 2020 | 2937 | 0.040 |
Why?
|
Piperidines | 2 | 2017 | 1669 | 0.040 |
Why?
|
Neuroblastoma | 1 | 2006 | 1266 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 551 | 0.040 |
Why?
|
Circular Dichroism | 1 | 2018 | 337 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 690 | 0.040 |
Why?
|
Research Personnel | 1 | 2022 | 590 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2017 | 101 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 501 | 0.040 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2016 | 22 | 0.040 |
Why?
|
Transplantation Conditioning | 1 | 2024 | 1601 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1120 | 0.030 |
Why?
|
Cell Membrane | 1 | 2006 | 3659 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 395 | 0.030 |
Why?
|
Zebrafish | 1 | 2008 | 3037 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1714 | 0.030 |
Why?
|
Dermis | 1 | 2017 | 203 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 840 | 0.030 |
Why?
|
Cell-Free System | 1 | 2016 | 340 | 0.030 |
Why?
|
Graphite | 1 | 2016 | 79 | 0.030 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 40 | 0.030 |
Why?
|
Pathology | 1 | 2019 | 270 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 221 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 252 | 0.030 |
Why?
|
Receptors, Interleukin-21 | 1 | 2015 | 32 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2019 | 12809 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 2018 | 694 | 0.030 |
Why?
|
Protein Conformation | 2 | 2014 | 3956 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2017 | 2395 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.030 |
Why?
|
Hyperkeratosis, Epidermolytic | 1 | 1994 | 7 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2009 | 2896 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 40266 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2014 | 2592 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 187 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1751 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11934 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2017 | 453 | 0.030 |
Why?
|
Calorimetry | 1 | 1995 | 132 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 583 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 2016 | 385 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 200 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1246 | 0.030 |
Why?
|
Gene Products, tax | 1 | 2014 | 51 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 354 | 0.030 |
Why?
|
Antimitotic Agents | 1 | 2014 | 28 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2016 | 663 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2431 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2041 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 139 | 0.030 |
Why?
|
Nephrectomy | 1 | 2019 | 949 | 0.030 |
Why?
|
Proteome | 2 | 2016 | 1891 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1519 | 0.030 |
Why?
|
HTLV-I Infections | 1 | 2014 | 104 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1567 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 349 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 362 | 0.030 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2014 | 143 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2013 | 2885 | 0.030 |
Why?
|
Teratoma | 1 | 2016 | 405 | 0.030 |
Why?
|
Threonine | 1 | 2014 | 273 | 0.030 |
Why?
|
Caspase 8 | 1 | 2014 | 198 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14485 | 0.030 |
Why?
|
Disease | 1 | 2019 | 673 | 0.030 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2014 | 168 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 524 | 0.030 |
Why?
|
Molecular Structure | 1 | 2017 | 1885 | 0.030 |
Why?
|
Ichthyosiform Erythroderma, Congenital | 1 | 1992 | 7 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2231 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1078 | 0.030 |
Why?
|
Methylnitronitrosoguanidine | 1 | 2012 | 18 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2018 | 2227 | 0.030 |
Why?
|
Chickens | 1 | 1995 | 845 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2017 | 542 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2022 | 2167 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2269 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2931 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2017 | 2695 | 0.020 |
Why?
|
Caspase 3 | 1 | 2014 | 731 | 0.020 |
Why?
|
Breast | 1 | 2020 | 1976 | 0.020 |
Why?
|
Nanostructures | 1 | 2016 | 553 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2396 | 0.020 |
Why?
|
Conserved Sequence | 1 | 1995 | 1162 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 878 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2013 | 432 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 701 | 0.020 |
Why?
|
Child | 3 | 2019 | 80969 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 875 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3744 | 0.020 |
Why?
|
Blood Cells | 1 | 2013 | 309 | 0.020 |
Why?
|
Glycolipids | 1 | 2011 | 205 | 0.020 |
Why?
|
Acrylamides | 1 | 2012 | 261 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2081 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 805 | 0.020 |
Why?
|
Biosensing Techniques | 1 | 2016 | 662 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2204 | 0.020 |
Why?
|
Proline | 1 | 1992 | 455 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2981 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1422 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1739 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2019 | 2059 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 60110 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2018 | 2452 | 0.020 |
Why?
|
Polyribonucleotides | 1 | 1988 | 4 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2896 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 1995 | 1262 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3580 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 4940 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6023 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22294 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 808 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2843 | 0.020 |
Why?
|
Mitosis | 1 | 2014 | 1181 | 0.020 |
Why?
|
Sepharose | 1 | 1988 | 102 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1769 | 0.020 |
Why?
|
Base Composition | 1 | 1988 | 291 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2163 | 0.020 |
Why?
|
Amino Acids | 1 | 1995 | 1716 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 1988 | 290 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2905 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1894 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3588 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1339 | 0.020 |
Why?
|
Pancreas Transplantation | 1 | 1989 | 193 | 0.020 |
Why?
|
Guinea Pigs | 1 | 2009 | 1309 | 0.020 |
Why?
|
Homeostasis | 1 | 2019 | 3348 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6289 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
Biological Evolution | 1 | 1993 | 1078 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 1988 | 351 | 0.020 |
Why?
|
Cell Movement | 2 | 2011 | 5216 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2909 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4784 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6805 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3238 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7245 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12469 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4926 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1973 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4432 | 0.020 |
Why?
|
Gene Amplification | 1 | 2010 | 1099 | 0.020 |
Why?
|
Plasmacytoma | 1 | 2005 | 170 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 3102 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7609 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1169 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1989 | 1439 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2848 | 0.010 |
Why?
|
Tissue Donors | 1 | 2014 | 2382 | 0.010 |
Why?
|
Attachment Sites, Microbiological | 1 | 2003 | 26 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7057 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3112 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2014 | 2682 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7472 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 419 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2606 | 0.010 |
Why?
|
Integrases | 1 | 2003 | 520 | 0.010 |
Why?
|
Rats | 2 | 1995 | 23847 | 0.010 |
Why?
|
Antigens, CD19 | 1 | 2003 | 446 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6213 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9384 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10397 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5803 | 0.010 |
Why?
|
Spleen | 1 | 2003 | 2294 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36541 | 0.010 |
Why?
|
NF-kappa B | 1 | 2005 | 2492 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42684 | 0.010 |
Why?
|
Gene Deletion | 1 | 2003 | 2674 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2005 | 3782 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54950 | 0.010 |
Why?
|
Alleles | 1 | 2003 | 6901 | 0.010 |
Why?
|
Epidermis | 1 | 1994 | 539 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 89247 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 3540 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 81892 | 0.010 |
Why?
|
Cytokines | 1 | 2003 | 7453 | 0.000 |
Why?
|
Oligonucleotides | 1 | 1991 | 563 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1989 | 1163 | 0.000 |
Why?
|
Genetic Engineering | 1 | 1992 | 936 | 0.000 |
Why?
|
Perfusion | 1 | 1989 | 1402 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1991 | 4123 | 0.000 |
Why?
|
Islets of Langerhans | 1 | 1989 | 1351 | 0.000 |
Why?
|
Pancreas | 1 | 1989 | 1700 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1991 | 6512 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1989 | 9264 | 0.000 |
Why?
|